The study, published in the Journal of Clinical Pathways, analyzed data from nearly 13,500 patients who received chemotherapy between Sep. 1, 2020, and Aug. 31, 2022. Patients who underwent home redirection were 32 percent less likely to have incidences of neutropenia, fever, pneumonia and sepsis.
The odds of same-day pegfilgrastim administration were 43 percent lower in patients who underwent home redirection, according to the study.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
